Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease

Clinical and Vaccine Immunology

Volumn 15, Issue 10, 2008, Pages 1519-1522

  Wormser, Gary P ^a   Nowakowski, John ^a   Nadelman, Robert B ^a   Visintainer, Paul ^a   Levin, Andrew ^b   Aguero Rosenfeld, Maria E ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b IMMUNETICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; BACTERIUM CULTURE; BORRELIA BURGDORFERI; CONTROLLED STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NORTH AMERICA; PRIORITY JOURNAL; SEROLOGY; AGE; ANIMAL; BLOOD; COMPARATIVE STUDY; HOSPITALIZATION; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SEX DIFFERENCE; TIME;

ADULT; AGE FACTORS; ANIMALS; ANTIBODIES, BACTERIAL; BORRELIA BURGDORFERI; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LYME DISEASE; MALE; MIDDLE AGED; NORTH AMERICA; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIME FACTORS;

EID: 55449098849     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00109-08     Document Type: Article

References (14)

1. Aguero-Rosenfeld, M. E., J. Nowakowski, S. Bittker, D. Cooper, R. B. Nadelman, and G. P. Wormser. 1996. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J. Clin. Microbiol. 34:1-9.
2. Aguero-Rosenfeld, M. E., J. Nowakowski, D. F. McKenna, C. A. Carbonaro, and G. P. Wormser. 1993. Serodiagnosis in early Lyme disease. J. Clin. Microbiol. 31:3090-3095.
3. Aguero-Rosenfeld, M. E., G. Wang, I. Schwartz, and G. P. Wormser. 2005. Diagnosis of Lyme borreliosis. Clin. Microbiol. Rev. 18:484-509.
4. Bacon, R. M., B. J. Biggerstaff, M. E. Schriefer, R. D. Gilmore, Jr., M. T. Philipp, A. C. Steere, G. P. Wormser, A. R. Marques, and B. J. Johnson. 2003. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J. Infect. Dis. 187:1187-1199.
5. Birdsall, H. H. 2005. Antibodies, p. 52-59. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 6th ed. Elsevier Churchill Livingstone, Philadelphia, PA.
6. Centers for Disease Control and Prevention. 1995. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb. Mortal. Wkly. Rep. 44:590-591.
7. Cetin, E., M. Sotoudeh, H. Auer, and G. Stanek. 2006. Paradigm Burgenland: risk of Borrelia burgdorferi sensu lato infection indicated by variable seroprevalence rates in hunters. Wien. Klin. Wochenschr. 118:677-681.
8. Lawrenz, M. B., J. M. Hardham, R. T. Owens, J. Nowakowski, A. C. Steere, G. P. Wormser, and S. J. Norris. 1999. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J. Clin. Microbiol. 37: 3997-4004.
9. Liang, F. T., A. C. Steere, A. R. Marques, B. J. Johnson, J. N. Miller, and M. T. Philipp. 1999. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J. Clin. Microbiol. 37:3990-3996.
10. Mitchell, P. D., K. D. Reed, T. L. Aspeslet, M. F. Vandermause, and J. W. Melski. 1994. Comparison of four immunoserologic assays for detection of antibodies to Borrelia burgdorferi in patients with culture-positive erythema migrans. J. Clin. Microbiol. 32:1958-1962.
11. Vaz, A., L. Glickstein, J. A. Field, G. McHugh, V. K. Sikand, N. Damle, and A. C. Steere. 2001. Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease. Infect. Immun. 69:7437-7444.
12. Wormser, G. P., R. J. Dattwyler, E. D. Shapiro, J. J. Halperin, A. C. Steere, M. S. Klempner, P. J. Krause, J. S. Bakken, F. Strle, G. Stanek, L. Bockenstedt, D. Fish, J. S. Dumler, and R. B. Nadelman. 2006. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 43:1089-1134.
13. Wormser, G. P., D. Liveris, K. Hanincova, D. Brisson, S. Ludin, V. J. Stracuzzi, M. E. Embers, M. T. Philipp, A. Levin, M. Aguero-Rosenfeld, and I. Schwartz. 2008. Effect of Borrelia burgdorferi genotype on the sensitivity of C6 and two-tier testing in North American patients with culture-confirmed Lyme disease. Clin. Infect. Dis. 47:910-914.
14. Wormser, G. P., D. Liveris, J. Nowakowski, R. B. Nadelman, L. F. Cavaliere, D. McKenna, D. Holmgren, and I. Schwartz. 1999. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease. J. Infect. Dis. 180:1720-725.